SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa

Morgante, F; Artusi, CA; Ricciardi, L; Sarchioto, M; Montanaro, E; Edwards, MJ; Lopiano, L; Zibetti, M (2025) Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa. European Journal of Neurology, 32 (9). e70342. ISSN 1351-5101 https://doi.org/10.1111/ene.70342
SGUL Authors: Morgante, Francesca

[img] PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (1MB)
[img] Microsoft Word (.docx) (Tables S1-S4) Supporting information
Download (26kB)

Abstract

Background The factors contributing to a poor response to subthalamic nucleus deep brain stimulation (STN‐DBS) in Parkinson's disease (PD) are not yet fully understood. Accordingly, predicting the outcome might be challenging particularly in those who display an optimal response to the Levodopa challenge test. Objective To determine which factors may contribute to poor outcome of STN‐DBS in PD. Methods We performed a retrospective analysis of consecutive PD patients treated with STN‐DBS. Motor and non‐motor variables were retrieved before surgery and at 1‐year follow‐up. Patients were divided into poor and good DBS responders by a cut‐off value of less than 20% improvement of UPDRS‐II in the OFF‐medication ON‐stimulation condition at 1 year. Results Thirty‐two (26.2%) of 122 patients were categorised as poor responders. Before surgery, poor responders had significantly less impairment in activity of daily living and less severe motor severity. Response to levodopa challenge test was similar between poor and good responders. Significant worsening of axial symptoms at 1‐year follow‐up in the off‐medication off‐stimulation condition was found in poor responders. On multivariable linear regression analysis, only the relative change of activity of daily living by dopaminergic medications before surgery predicted its improvement by neurostimulation at 1‐year follow‐up. Conclusions Candidates for surgery with less impairment in activities of daily living may have less favourable outcomes after STN‐DBS, despite an optimal response during the pre‐operative Levodopa challenge. The worsening of axial symptoms due to disease progression might contribute to poorer outcomes, underscoring the need for better identification of these symptoms before surgery.

Item Type: Article
Additional Information: © 2025 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
SGUL Research Institute / Research Centre: Academic Structure > Neuroscience & Cell Biology Research Institute
Academic Structure > Neuroscience & Cell Biology Research Institute > Neuromodulation & Motor Control
Journal or Publication Title: European Journal of Neurology
ISSN: 1351-5101
Language: en
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Dates:
Date Event
2025-09-08 Published
2025-08-07 Accepted
URI: https://openaccess.sgul.ac.uk/id/eprint/117888
Publisher's version: https://doi.org/10.1111/ene.70342

Actions (login required)

Edit Item Edit Item